Panacea Index Logo

Command Palette

Search for a command to run...

Reducing saturated fat intake lowers LDL-C but increases Lp(a) levels in African Americans: the GET-READI feeding trial.

Journal of lipid research
September 1, 2023
Hayley G Law et al. (9 authors)
Randomized Controlled TrialJournal ArticleResearch Support, N.I.H., ExtramuralHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine the effects of reducing dietary saturated fatty acids (SFA) on lipoprotein(a) [Lp(a)] levels and cardiovascular risk factors in African Americans.

Results Summary

Reducing SFA intake significantly lowered LDL-C and other lipid markers but unexpectedly increased Lp(a) levels in African Americans. The DASH-type diet (6% SFA) showed stronger effects than the average American diet (16% SFA).

Population

166 African Americans (70% women, mean age 35, mean BMI 28 kg/m²).

Effective Dosage

Two diets—37% total fat (16% SFA) vs. 25% total fat (6% SFA).

Duration

5 weeks per diet.

Interactions

None mentioned

Extracted Claims (10)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Reducing dietary saturated fatty acids (SFA) intake
decrease
low-density lipoprotein cholesterol (LDL-C)
across ethnicities
clinically significant
results in a clinically significant lowering
#1
dietary SFA reduction
neutral
Lp(a) levels
166 African Americans
-
assessed the responses
#2
DASH-type diet
decrease
LDL-C
166 African Americans
-12 mg/dl
reduced
#3
DASH-type diet
decrease
total cholesterol
166 African Americans
-16 mg/dl
reduced
#4
DASH-type diet
decrease
HDL-C
166 African Americans
-5 mg/dl
reduced
#5
DASH-type diet
decrease
apoA-1
166 African Americans
-9 mg/dl
reduced
#6
DASH-type diet
decrease
apoB-100
166 African Americans
-5 mg/dl
reduced
#7
DASH-type diet
increase
Lp(a) levels
166 African Americans
58 vs. 44 mg/dl
increased
#8
reductions in SFA intake
increase
Lp(a) levels
African Americans
significantly
significantly increased
#9
reductions in SFA intake
decrease
LDL-C
African Americans
-
reducing
#10
Abstract

Reducing dietary saturated fatty acids (SFA) intake results in a clinically significant lowering of low-density lipoprotein cholesterol (LDL-C) across ethnicities. In contrast, dietary SFA's role in modulating emerging cardiovascular risk factors in different ethnicities remains poorly understood. Elevated levels of lipoprotein(a) [Lp(a)], an independent cardiovascular risk factor, disproportionally affect individuals of African descent. Here, we assessed the responses in Lp(a) levels to dietary SFA reduction in 166 African Americans enrolled in GET-READI (The Gene-Environment Trial on Response in African Americans to Dietary Intervention), a randomized controlled feeding trial. Participants were fed two diets in random order for 5 weeks each: 1) an average American diet (AAD) (37% total fat: 16% SFA), and 2) a diet similar to the Dietary Approaches to Stop Hypertension (DASH) diet (25% total fat: 6% SFA). The participants' mean age was 35 years, 70% were women, the mean BMI was 28 kg/m2, and the mean LDL-C was 116 mg/dl. Compared to the AAD diet, LDL-C was reduced by the DASH-type diet (mean change: -12 mg/dl) as were total cholesterol (-16 mg/dl), HDL-C (-5 mg/dl), apoA-1 (-9 mg/dl) and apoB-100 (-5 mg/dl) (all P < 0.0001). In contrast, Lp(a) levels increased following the DASH-type diet compared with AAD (median: 58 vs. 44 mg/dl, P < 0.0001). In conclusion, in a large cohort of African Americans, reductions in SFA intake significantly increased Lp(a) levels while reducing LDL-C. Future studies are warranted to elucidate the mechanism(s) underlying the SFA reduction-induced increase in Lp(a) levels and its role in cardiovascular risk across populations.

Medical Subject Headings (MeSH)
AdultFemaleHumansMaleBlack or African AmericanCholesterol, LDLDietDietary FatsLipoprotein(a)
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations7
Citations/Year3.5
Relative Citation Ratio1.46
NIH Percentile64.1%
Research Impact Scores
APT Score0.75
Weight Score19.25
Normalized Score0.67
Related Supplements